News

Photo

Achema Will not Take Place in 2021

Achema 2021 will be postponed by almost a year to the beginning of April 2022. The decision to break the 3-year cycle was made in view of the continuing uncertainty caused by the corona pandemic after intensive discussions with the community and in the Achema Committee.

Photo

Croda Supplies Excipients for Pfizer’s Covid-19 Vaccine

UK specialty chemical company Croda International has agreed to supply Pfizer with novel excipients used to make the drugmaker’s Covid-19 vaccine candidate. The contract, which is for a term of five years, enables Croda to initially supply four component excipients for the first three years of the agreement.

Photo

Sasol Starts LDPE Unit at Lake Charles

South African chemical group Sasol has started up the seventh and last plant at its glitch-plagued Lake Charles Chemicals Project (LCCP) in Lake Charles, Louisiana, USA. The 420,000 t/y LDPE facility, which uses ExxonMobil technology, was originally planned to start up in January 2019, but was damaged by an explosion and fire during commissioning.

Photo

Grasim Sells Fertilizer Unit to Indorama

India’s Grasim Industries has agreed to sell its fertilizer business Indo Gulf Fertilisers (IGF) to Indorama India Private, a subsidiary of Singapore’s Indorama Corp., for a cash sum of about $355 million.

Photo

Iktos and Merck Link on AI Drug Design

Iktos, a French company specialized in Artificial Intelligence (AI) for new drug design, has launched a collaboration with German pharmaceuticals, chemicals and life sciences group Merck.

Photo

McDermott Wins Follow-up Russian Cracker Contract

US engineering contractor McDermott International has been awarded a follow-up contract for the ethane cracker complex being built by China National Chemical Engineering & Construction Corporation Seven (CC7) for the Baltic Chemical Plant (BCP) in the Russian Baltic seaport of Ust-Luga.

Photo

W. R. Grace Rejects 40 North Takeover

US specialty chemical company W. R. Grace has rejected a takeover offer by shareholder 40 North Management, stating it “undervalues the company and is not a basis for further discussion.” The offer at $60 per share valued Grace at $4 billion.

Photo

Pfizer-BioNTech Pledge 300 Million Vaccine Doses to EU

US drugmaker Pfizer and its German development partner BioNTech have reached a final agreement with the European Commission to supply 200 million doses of their mRNA-based Covid19 vaccine candidate to the EU’s member states at an undisclosed price.

Photo

Stolt and John T. Essberger in Shipping JV

Stolt Tankers, the wholly owned subsidiary of Norway’s Stolt-Nielsen, has entered into a joint venture with Germany’s John T. Essberger Group to operate a combined fleet of chemical tankers within Europe.

Photo

Thermo Fisher and Innoforce Plan Chinese JV

US scientific equipment manufacturer Thermo Fisher Scientific and China-based CDMO Innoforce have formed a joint venture to own and operate a new pharma services facility for integrated biologics and sterile drug development and manufacturing in Hangzhou, China. Start date for the new entity is 2022.

Photo

ADNOC and ADQ Plan Chemical Projects in Abu Dhabi

Ta’ziz, a joint venture between Abu Dhabi National Oil Company (ADNOC) and compatriot holding company ADQ, will invest more than $5 billion in seven chemical anchor projects and related infrastructure within the planned Ruwais Derivatives Park in Abu Dhabi.

Photo

Lonza Opens new Plant for ADC Payload Manufacturing

Swiss CDMO Lonza has inaugurated the first of two planned state-of-the-art, highly-potent API (HPAPI) suites for antibody-drug conjugate (ADC) drug-linker (payload) manufacturing at its site in Visp, Switzerland. The new facility can handle compounds with occupational exposure levels down to 1ng/m3.

Photo

IMCD to Buy Peak’s Pharma Business

Dutch specialty chemicals and ingredients distributor IMCD has entered into an agreement to buy the pharmaceutical business of compatriot firm Peak International Products for an undisclosed sum.

Photo

Neste and LG Chem Partner on Renewables

Neste and South Korean petrochemicals giant LG Chem have formed a long-term partnership with the aim of developing and growing the global biopolymers and biochemicals market, and more specifically, LG Chem’s domestic market.

Photo

Pfizer-BioNTech Vaccine Claimed 90% Effective

Phase 3 clinical trials with the mRNA vaccine candidate BNT162b2 being developed by US pharma giant Pfizer and German biotech partner BioNTech have shown it to be more than 90% effective in preventing Covid-19 in participants without evidence of prior SARS-CoV-2 infection, the companies announced in a preliminary look at efficacy.

Photo

Major Indian Chemical Complex Put on Ice

Following completion of a comprehensive feasibility study, tentative plans for a major petrochemical complex in India have been shelved for now, due to what the prospective international project partners said were global economic uncertainties caused by the Covid-19 pandemic.

Photo

Linde to Produce Green Hydrogen in California

Industrial gases giant Linde plans to begin producing green hydrogen at its plant in Ontario, California, in the near future. With the unquantified investment, the enlarged, now UK-based group said it will be able to provide green hydrogen to fuel up to 1,600 vehicles a day and help avoid up to 50,000 t of CO2 per year.

Photo

Adama to Take Control of China’s Huifeng

Israeli crop protection producer Adama has entered into an agreement that will see it take a majority stake in most of Huifeng Bio Agriculture’s synthesis and formulation facilities.

Photo

Moderna Taps Takeda to Distribute Vaccine in Japan

US vaccine manufacturer Moderna has tapped Takeda as marketing partner for its Covid-19 vaccine candidate mRNA-1273f in Japan. Financial terms of the deal were not disclosed. The Japanese drugmaker will import and distribute the vaccine starting in the first half of next year as well as handle local regulatory approvals. The original contract is for 50 million doses.

Photo

Celanese Expands UHMW-PE Capacity in USA

Celanese will add a new line at its plant in Bishop, Texas, USA, for its GUR brand of ultra-high molecular weight polyethylene (UHMW-PE) to support significant market growth. The new line will add about 15,000 t/y of capacity by the start of 2022.

Photo

ACG Takes Stake in Drug Development Start-up

India’s ACG, a provider of pharmaceutical packaging, engineering equipment and inspection systems, has acquired a “significant” stake in compatriot start-up Iqgen-X, a contract research organization (CRO) that delivers niche and complex drug development technologies for the pharmaceutical industry.

Photo

Proman Joins North-C-Methanol Project

Swiss project management and construction services company Proman has joined nine private- and public-sector partners to mark the launch of the North-C-Methanol project, touted as the largest renewable hydrogen-to-methanol complex in the world.

Photo

Minaris Expands in Germany and Japan

Minaris Regenerative Medicine, a leading contract development and manufacturing organization for cell and gene therapies, has announced plans to invest $64.5 million to significantly expand its facilities in Germany and Japan.

Photo

Merck Expands OLED Output in Asia

Merck KGaA is expanding its production of organic light-emitting diodes (OLEDs) with a €20 million investment in Asia. Capacity additions are planned at sites in Pyeongtaek, South Korea, and Shanghai, China. The enhanced local capacities are intended to strengthen the German group’s position as a key supplier of high-purity OLED materials for panel makers in the region.

Photo

Huntsman Inaugurates Polyols Unit in Taiwan

Huntsman recently inaugurated its new plant for aromatic polyester polyols, which began production in May this year at the US chemical producer’s polyurethanes systems house in Kuan Yin, Taiwan.

10688 more News

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.